PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 70 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309,249 | +78.7% | 1,037,747 | -0.8% | 0.00% | – |
| Q2 2023 | $173,089 | -85.4% | 1,045,852 | -14.0% | 0.00% | – |
| Q1 2023 | $1,187,505 | -14.2% | 1,216,706 | -8.6% | 0.00% | – |
| Q4 2022 | $1,384,104 | -9.5% | 1,330,869 | +0.1% | 0.00% | – |
| Q3 2022 | $1,529,000 | -38.9% | 1,329,749 | -0.7% | 0.00% | – |
| Q2 2022 | $2,504,000 | -38.2% | 1,338,776 | +0.0% | 0.00% | – |
| Q1 2022 | $4,055,000 | -18.6% | 1,338,437 | +1.6% | 0.00% | – |
| Q4 2021 | $4,979,000 | -24.6% | 1,317,287 | +3.2% | 0.00% | – |
| Q3 2021 | $6,602,000 | +32.4% | 1,276,990 | -2.0% | 0.00% | – |
| Q2 2021 | $4,988,000 | -47.3% | 1,302,450 | -64.6% | 0.00% | – |
| Q1 2021 | $9,458,000 | +4.2% | 3,680,362 | +1.4% | 0.00% | – |
| Q4 2020 | $9,079,000 | +23.1% | 3,631,309 | +1.9% | 0.00% | – |
| Q3 2020 | $7,377,000 | -33.3% | 3,563,573 | -0.2% | 0.00% | – |
| Q2 2020 | $11,068,000 | +44.6% | 3,570,098 | +6.3% | 0.00% | – |
| Q1 2020 | $7,655,000 | -37.9% | 3,357,550 | -1.4% | 0.00% | – |
| Q4 2019 | $12,326,000 | +8.4% | 3,405,125 | +2.1% | 0.00% | – |
| Q3 2019 | $11,370,000 | -0.4% | 3,334,643 | +37.4% | 0.00% | – |
| Q2 2019 | $11,410,000 | +32.4% | 2,427,425 | -5.6% | 0.00% | – |
| Q1 2019 | $8,615,000 | +20.6% | 2,571,463 | -4.3% | 0.00% | – |
| Q4 2018 | $7,146,000 | -52.5% | 2,686,379 | -0.0% | 0.00% | -100.0% |
| Q3 2018 | $15,051,000 | +10.5% | 2,687,508 | +0.1% | 0.00% | 0.0% |
| Q2 2018 | $13,616,000 | +10.8% | 2,685,490 | +49.1% | 0.00% | 0.0% |
| Q1 2018 | $12,284,000 | +1.9% | 1,801,142 | +12.8% | 0.00% | 0.0% |
| Q4 2017 | $12,053,000 | +36.9% | 1,596,382 | +4.4% | 0.00% | – |
| Q3 2017 | $8,805,000 | +17.1% | 1,528,487 | +2.8% | 0.00% | – |
| Q2 2017 | $7,522,000 | +3128.3% | 1,486,572 | +1559.3% | 0.00% | – |
| Q1 2017 | $233,000 | – | 89,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |